• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Mechanisms underlying resistance of the bacteria responsible for nosocomial infections].

作者信息

Mainardi J L, Gutmann L

机构信息

Laboratoire de Microbiologie Médicale, Fondation Hôpital Saint-Joseph, Paris, France.

出版信息

Pathol Biol (Paris). 1998 Apr;46(4):253-60.

PMID:9769905
Abstract

Resistance of nosocomial bacteria to antimicrobials is due to both natural and acquired factors. Production of inactivating enzymes (beta-lactamases, aminoglycoside detoxifying enzymes) is the most common mechanism in Gram-negative bacteria. The concomitant presence of other mechanisms such as abnormalities in the targets (for fluoroquinolones), permeability, or efflux of antimicrobials, explains why many nosocomial strains are resistant to multiple drugs. In Gram-positive bacteria, the main mechanism involves modifications in the bacterial targets of antimicrobials; for instance, changes in penicillin-binding proteins lead to penicillin resistance in enterococci and to methicillin resistance in staphylococci, whereas changes in peptidoglycans result in glycopeptide resistance in enterococci. As is the case for Gram-negative bacteria, the concomitant presence of other mechanisms is common, and as a result many nosocomial strains are multiresistant.

摘要

相似文献

1
[Mechanisms underlying resistance of the bacteria responsible for nosocomial infections].
Pathol Biol (Paris). 1998 Apr;46(4):253-60.
2
In vitro activity of ertapenem: review of recent studies.厄他培南的体外活性:近期研究综述
J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii11-21. doi: 10.1093/jac/dkh204.
3
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.针对重症监护病房住院患者的医院内细菌病原体测试替加环素的抗菌活性。
Diagn Microbiol Infect Dis. 2005 Jul;52(3):203-8. doi: 10.1016/j.diagmicrobio.2005.05.002.
4
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.针对引起社区获得性呼吸道感染和医院获得性肺炎的病原体测试替加环素的抗菌活性。
Diagn Microbiol Infect Dis. 2005 Jul;52(3):187-93. doi: 10.1016/j.diagmicrobio.2005.05.004.
5
[The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].[细胞壁组织和主动外排泵系统在细菌多重耐药性中的作用]
Mikrobiyol Bul. 2007 Apr;41(2):309-27.
6
[Distribution of pathogen and resistance of nosocomial infections in the intensive care units].[重症监护病房医院感染的病原菌分布及耐药性]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Apr;31(2):277-80.
7
Emergence and mechanisms of bacterial resistance in surgical infections.外科感染中细菌耐药性的出现及其机制
Am J Surg. 1995 May;169(5A Suppl):13S-20S.
8
Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.1996 - 2003年台湾南部某大学医院院内血流感染中革兰氏阴性杆菌的优势及抗菌药物耐药性增加情况
J Microbiol Immunol Infect. 2006 Apr;39(2):135-43.
9
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.头孢洛林(PPI-0903M,T-91825)对具有明确耐药机制和表型的细菌的体外活性。
J Antimicrob Chemother. 2007 Aug;60(2):300-11. doi: 10.1093/jac/dkm150. Epub 2007 Jun 4.
10
Antimicrobial resistance in Europe and its potential impact on empirical therapy.欧洲的抗菌药物耐药性及其对经验性治疗的潜在影响。
Clin Microbiol Infect. 2008 Dec;14 Suppl 6:2-8. doi: 10.1111/j.1469-0691.2008.02126.x.